System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Prof Denis Pezet is an expert in Surgery at Centre Hospitalier Universitaire de Clermont-Ferrand (France). As of October 2026, ScienceLeadR ranks Denis Pezet in the top 1% of experts worldwide for Intestinal Neoplasms, Gastrointestinal Neoplasms and Colonic Diseases. Denis Pezet has authored 380 publications, the most recent in 2026, and is an investigator in 40 clinical trials, 3 of them ongoing. SLR score: 1,188 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Denis Pezet Centre Hospitalier Universitaire de Clermont-Ferrand France
1 188 ScienceLeadR Reputation 1188

Unlock

Register Login
Network Map

Surgery

Subspecialties: Oncology - Gastroenterology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1988 - 2026
Source: PubMed

INSERM

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 380

Citations

Citations: 18 612 1st author: 8 Last author: 20 Unique author: 1

Main journals

J Clin Oncol 24
Ann Oncol 16
Ann Surg Oncol 13
Eur J Cancer 13
Eur J Surg Oncol 12

Best Journals

Lancet Oncol 4
Ann Oncol 3
Lancet 3

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Early Portomesenteric Thrombosis Following Pancreaticoduodenectomy: Risk Factors, Management and Outcomes.
PMID 42144800 — mortality, blood, pancreaticoduodenectomy, neoplasms, risk factors, thrombosis		J Surg Oncol20260
Corrigendum to "Combination of CDX2H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer" [In European Journal of Cancer, Volume 172, 2022, Pages 221-230, ISSN 0959-8049].
PMID 41946180 — neoplasms, colon, artificial intelligence, prognosis, colonic neoplasms		Eur J Cancer20260
The clinical benefit of a near complete cytoreduction in patients with colorectal peritoneal metastases: a propensity score matched study.
PMID 41576516 — neoplasms, hyperthermic intraperitoneal chemotherapy, propensity score, drug therapy, neoplasm metastasis, therapeutics, laparotomy, chemotherapy		Eur J Surg Oncol20260
How are duodenal trauma managed? A French nationwide study.
PMID 41366408 — mortality, surgical procedures, operative, morbidity, wounds and injuries, laparotomy, hemodynamics		World J Emerg Surg20250
ASO Visual Abstract: Does Splenic Hilar Lymph Node Harvesting Impact Outcomes following Total Gastrectomy for Cancer? A Multi-Institutional Retrospective Study with Propensity Score Matching.
PMID 41359219 — lymph nodes, retrospective studies, neoplasms, multiple chronic conditions, propensity score, lymph, gastrectomy		Ann Surg Oncol20250

Clinical Studies 40

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5

By phase:

N/A 17
Phase 3 10
Phase 2 8
Phase 1/Phase 2 2
Phase 4 2
Phase 2/Phase 3 1

By status:

Completed 24
Unknown 8
Recruiting 3
Active not recruiting 2
Not yet recruiting 1
Suspended 1
Terminated 1

By type:

Interventional 28
Observational 12

By Monocentric/Multicentric:

monocentric 17
multicentric2to4 1
multicentric5to9 2
multicentricup10 20

Main Topics

Cohort/Consortium Investigators 5

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Chemotherapy in the Context of Esophageal and Gastroesophageal Junction Cancer Cachexia
NCT05954117 — anesthesia, general, anesthesia, subcutaneous fat, abdominal, muscles, subcutaneous fat, esophagus, esophagogastric junction, neoplasms, adenocarcinoma, mitochondria, biopsy, drug therapy, adipocytes, operative time, muscle strength, therapeutics, tissues, cachexia, adipose tissue, chemotherapy, cancer-associated cachexia		N/ANot yet recruiting2023
Peristomal Hernia Rate 5 Years After a Terminal Colostomy With the Parietex TCM Parietal Prosthesis Versus Without Mesh
NCT04282473 — hernia, epidemiology, colostomy		N/ARecruiting2022
Chemotherapy and Immunotherapy as Treatment for MSS Metastatic Colorectal Cancer With High Immune Infiltrate
NCT04262687 — cells, dna mismatch repair, microsatellite repeats, lymphocytes, antibodies, neoplasms, bevacizumab, drug therapy, oxaliplatin, immunotherapy, proof of concept study, immunity, therapeutics, colorectal neoplasms, capecitabine, tissues, biological factors, chemotherapy		Phase 2Recruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS